Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness: from whose perspective?

A L Hillman1

  • 1School of Medicine, University of Pennsylvania, Philadelphia, USA.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

700,000 years of tropical Andean glaciation.

Nature·2022
Same author

Financial incentives and drug spending in managed care.

LDI issue brief·2003
Same author

Creating illegal immigrants.

Journal of population economics·2002
Same author

HMO behavior and stock market valuation: what does Wall Street reward and punish?

Journal of health care finance·2001
Same author

The future catches up: a medical school curriculum in health economics.

The American journal of the medical sciences·2000
Same author

Financial incentives and drug spending in managed care.

Health affairs (Project Hope)·1999
Same journal

Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments?

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Mortality risk in selenium-deficient HIV-positive children.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Predictors and risk-taking consequences of drug use among HIV-infected women.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Correlates of condom failure in a sexually active cohort of men who have sex with men.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
See all related articles

Minimizing bias in medical cost-effectiveness research is crucial for accurate patient outcomes. Implementing guidelines for administrative, methodological, and ethical parameters ensures unbiased economic research and enhances study validity.

Area of Science:

  • Health Economics
  • Medical Research Methodology

Background:

  • Evaluating the cost-effectiveness of medical interventions, especially pharmaceuticals, is a significant challenge.
  • Balancing optimal patient outcomes with healthcare costs, particularly for high-risk populations, requires careful consideration.
  • Limited existing guidelines in the country exacerbate the difficulty in conducting unbiased economic research.

Purpose of the Study:

  • To review issues surrounding bias in cost-effectiveness research.
  • To identify guidelines for minimizing bias in economic research.
  • To enhance the validity and utility of cost-effectiveness studies.

Main Methods:

  • Review of existing literature on bias in economic research.
  • Identification of administrative, methodology-based, and ethical parameters to minimize bias.

Related Experiment Videos

  • Analysis of strategies for unbiased economic research.

    • Main Results:

    • Bias is a serious concern in interpreting and validating cost-effectiveness studies.
    • Guidelines encompassing administrative, methodological, and ethical parameters can reduce bias.
    • Standardization and implementation of guidelines improve the validity of economic research.

    Conclusions:

    • Unbiased economic research is essential for informed healthcare decisions.
    • Key steps to achieve unbiased research include full disclosure, appropriate comparator selection, complete data release, and cooperation.
    • Implementing these measures will optimize study validity and patient outcomes.